1. Home
  2. RJF vs DXCM Comparison

RJF vs DXCM Comparison

Compare RJF & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Raymond James Financial Inc.

RJF

Raymond James Financial Inc.

SELL

Current Price

$166.29

Market Cap

32.4B

Sector

Finance

ML Signal

SELL

Logo DexCom Inc.

DXCM

DexCom Inc.

SELL

Current Price

$81.58

Market Cap

34.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RJF
DXCM
Founded
1962
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4B
34.4B
IPO Year
2005
2005

Fundamental Metrics

Financial Performance
Metric
RJF
DXCM
Price
$166.29
$81.58
Analyst Decision
Buy
Strong Buy
Analyst Count
16
29
Target Price
★ $182.21
$98.58
AVG Volume (30 Days)
1.0M
★ 4.6M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
★ 1.28%
N/A
EPS Growth
6.19
★ 47.18
EPS
★ 8.52
1.87
Revenue
★ $15,912,000,000.00
N/A
Revenue This Year
$11.44
$12.15
Revenue Next Year
$7.03
$10.45
P/E Ratio
★ $19.74
$44.71
Revenue Growth
★ 6.63
N/A
52 Week Low
$138.82
$56.72
52 Week High
$182.73
$92.59

Technical Indicators

Market Signals
Indicator
RJF
DXCM
Relative Strength Index (RSI) 55.96 48.61
Support Level $163.01 $62.02
Resistance Level $173.14 $90.89
Average True Range (ATR) 4.20 2.96
MACD 0.81 0.19
Stochastic Oscillator 63.37 34.32

Price Performance

Historical Comparison
RJF
DXCM

About RJF Raymond James Financial Inc.

Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, asset management, and capital markets services to individuals, corporations, and municipalities. The firm maintains an extensive catalog of products and services across its business lines. However, the wealth management franchise generates the bulk of its revenue and earnings through a vast network of more than 8,900 independent and employee-affiliated advisors, who collectively managed over $1.9 trillion in client assets as of fiscal year-end 2026. While Raymond James maintains a global footprint, the company derives more than 90% of its revenue and an even larger percentage of its operating income from the United States.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: